Health Care Innovation
Commentary
Drug importation is a dangerous idea that won’t die
A federal judge just struck down a program in Maine allowing state residents to import prescription drugs from foreign countries. The reason: it’s against federal law — and justifiably so. The importation of price-controlled foreign drugs severely undermines research into future cures, hurting patients in the long run. And more ...
Commentary
Letting patients buy Canadian drugs will only import trouble
Good news for American patients — prescription drugs are effectively on sale. Drug spending climbed just 2.5 percent in 2013. Drug cost growth has now lagged overall health inflation for four straight years. Naturally, Washington lawmakers are ignoring the cost problems plaguing the rest of the healthcare marketplace and focusing ...
Commentary
Healthcare’s Problem Is Not High Drug Prices
Is $84,000 too much to pay to save a life? That’s a question worth asking now that the insurance industry has declared war on what it has deemed outrageous prices for new specialty drugs. In this case, the complaints focus on Sovaldi, a breakthrough treatment that gives three million people ...
Health Care
Why Pharmaceutical Prices Drop Once Drugs Are Off-Patent
Today PRI released the new report The Economics of Pharmaceutical Pricing by PRI senior fellow Wayne Winegarden, Ph.D. The study examines the market forces influencing the often dramatic price differences in pharmaceutical drugs before and after their patents expire. Some critics erroneously see the sharp declines in the prices of ...
Commentary
Industry Succeeds Where Obamacare Fails
Walmart is about to get into the health insurance business. The retail giants Sams Club division just announced that it would launch a private health insurance exchange for its small-business customers. Business owners shopping at the wholesaler will effectively be able to pick up health insurance for their employees along ...
Commentary
The News Is The Declining Incentives For Medical Innovation
The federal health exchange Healthcare.gov, one of the centerpieces of the Affordable Care Act (ACA or ObamaCare), is gasping for life. This is not the important story, however. The U.S. health care system has flaws. And, these flaws should have been the focus of the health care reforms back in ...
Commentary
India’s War On Intellectual Property Rights May Bring With It A Body Count
Last month, drug maker Roche withdrew its patents for the breast-cancer drug Herceptin in India and thus gave tacit approval to other companies to make low-cost generic versions of the drug. But the withdrawal of those patents was not completely voluntary. If the Swiss pharmaceutical firm had not relinquished ...
Commentary
Government Mandates Don’t Lower Health Care Costs
Free lunches are often the most expensive meals. And yet, when it comes to the nations health care system, the federal government blindly offers free lunch buffets in lieu of policies that would actually address the core problems of the nations health care system. An example of this free lunch ...
Commentary
Bend The Healthcare Cost Curve Downward By Letting Healthcare Costs Rise
Earlier this year, a team of researchers in Europe decided to examine the relationship between cutting-edge technology and healthcare costs. Some wonks complain that expensive new medical technologies and therapies some of which deliver only marginal improvements to patient health are key drivers of health spending. But when ...
Commentary
Treating Alzheimer’s with regulations
Bureaucracy stands in the way of the best treatment The U.S. health care system is rife with rising costs and stagnating quality. All too often, the cure for these ailments calls for ever greater government intervention. Such cures misdiagnose the problem. The health care systems problems are caused by too ...
Drug importation is a dangerous idea that won’t die
A federal judge just struck down a program in Maine allowing state residents to import prescription drugs from foreign countries. The reason: it’s against federal law — and justifiably so. The importation of price-controlled foreign drugs severely undermines research into future cures, hurting patients in the long run. And more ...
Letting patients buy Canadian drugs will only import trouble
Good news for American patients — prescription drugs are effectively on sale. Drug spending climbed just 2.5 percent in 2013. Drug cost growth has now lagged overall health inflation for four straight years. Naturally, Washington lawmakers are ignoring the cost problems plaguing the rest of the healthcare marketplace and focusing ...
Healthcare’s Problem Is Not High Drug Prices
Is $84,000 too much to pay to save a life? That’s a question worth asking now that the insurance industry has declared war on what it has deemed outrageous prices for new specialty drugs. In this case, the complaints focus on Sovaldi, a breakthrough treatment that gives three million people ...
Why Pharmaceutical Prices Drop Once Drugs Are Off-Patent
Today PRI released the new report The Economics of Pharmaceutical Pricing by PRI senior fellow Wayne Winegarden, Ph.D. The study examines the market forces influencing the often dramatic price differences in pharmaceutical drugs before and after their patents expire. Some critics erroneously see the sharp declines in the prices of ...
Industry Succeeds Where Obamacare Fails
Walmart is about to get into the health insurance business. The retail giants Sams Club division just announced that it would launch a private health insurance exchange for its small-business customers. Business owners shopping at the wholesaler will effectively be able to pick up health insurance for their employees along ...
The News Is The Declining Incentives For Medical Innovation
The federal health exchange Healthcare.gov, one of the centerpieces of the Affordable Care Act (ACA or ObamaCare), is gasping for life. This is not the important story, however. The U.S. health care system has flaws. And, these flaws should have been the focus of the health care reforms back in ...
India’s War On Intellectual Property Rights May Bring With It A Body Count
Last month, drug maker Roche withdrew its patents for the breast-cancer drug Herceptin in India and thus gave tacit approval to other companies to make low-cost generic versions of the drug. But the withdrawal of those patents was not completely voluntary. If the Swiss pharmaceutical firm had not relinquished ...
Government Mandates Don’t Lower Health Care Costs
Free lunches are often the most expensive meals. And yet, when it comes to the nations health care system, the federal government blindly offers free lunch buffets in lieu of policies that would actually address the core problems of the nations health care system. An example of this free lunch ...
Bend The Healthcare Cost Curve Downward By Letting Healthcare Costs Rise
Earlier this year, a team of researchers in Europe decided to examine the relationship between cutting-edge technology and healthcare costs. Some wonks complain that expensive new medical technologies and therapies some of which deliver only marginal improvements to patient health are key drivers of health spending. But when ...
Treating Alzheimer’s with regulations
Bureaucracy stands in the way of the best treatment The U.S. health care system is rife with rising costs and stagnating quality. All too often, the cure for these ailments calls for ever greater government intervention. Such cures misdiagnose the problem. The health care systems problems are caused by too ...
